10-Q Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 Q1 2023

Filing Information

Form Type	10-Q
Accession Number	`0001213900-23-038533`
Period End Date	20230331
Filing Date	20230511
Fiscal Year	2023
Fiscal Period	Q1
XBRL Instance	f10q0323_relmadatherap_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 54 Income Statement 27 Cash Flow Statement 51 Stockholders Equity 16

Balance Sheet 54 line items

Line Item	Tag	Value	Unit	Period
Convertible preferred stock par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Convertible preferred stock par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Convertible preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.50M	shares	Point-in-time
Convertible preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.50M	shares	Point-in-time
Convertible preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Convertible preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.40M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$28.89M	USD	Point-in-time
Convertible preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$103.55M	USD	Point-in-time
Convertible preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$142.93M	USD	Point-in-time
Other receivables	`ReceivablesNetCurrent`	-	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other receivables	`ReceivablesNetCurrent`	$512.43K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$3.09M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$4.04M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.10M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.10M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$152.87M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$135.53M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$34.88K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.10M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$34.88K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.10M	shares	Point-in-time
Total assets	`Assets`	$135.57M	USD	Point-in-time
Total assets	`Assets`	$152.91M	USD	Point-in-time
Commitments and Contingencies (See Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (See Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$4.42M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.26M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$7.21M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$5.68M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.47M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$10.10M	USD	Point-in-time
Total liabilities	`Liabilities`	$10.10M	USD	Point-in-time
Total liabilities	`Liabilities`	$12.47M	USD	Point-in-time
Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, 150,000,000 shares authorized, 30,099,203 shares issued and outstanding	`CommonStockValue`	$30.10K	USD	Point-in-time
Common stock, $0.001 par value, 150,000,000 shares authorized, 30,099,203 shares issued and outstanding	`CommonStockValue`	$30.10K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$602.52M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$613.87M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-488.43M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-462.11M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$140.44M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$210.40M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$125.47M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$208.26M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$135.57M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$152.91M	USD	Point-in-time

Income Statement 27 line items

Line Item	Tag	Value	Unit	Period
Loss per common share diluted	`EarningsPerShareDiluted`	$-0.88	USD	1 Quarter
Loss per common share diluted	`EarningsPerShareDiluted`	$-1.40	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$25.01M	USD	Annual
Weighted average number of common shares outstanding Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	30.10M	shares	1 Quarter
Weighted average number of common shares outstanding Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	28.39M	shares	Annual
Research and development	`ResearchAndDevelopmentExpense`	$15.86M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$12.29M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$13.28M	USD	Annual
Total operating expenses	`OperatingExpenses`	$38.30M	USD	Annual
Total operating expenses	`OperatingExpenses`	$28.15M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-38.30M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-28.15M	USD	1 Quarter
Interest/investment income, net	`InterestIncomeExpenseNet`	$1.21M	USD	1 Quarter
Interest/investment income, net	`InterestIncomeExpenseNet`	$329.95K	USD	Annual
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-15.02K	USD	Annual
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-666.71K	USD	1 Quarter
Unrealized gain (loss) on short-term investments	`UnrealizedGainLossOnInvestments`	$1.29M	USD	1 Quarter
Unrealized gain (loss) on short-term investments	`UnrealizedGainLossOnInvestments`	$-1.76M	USD	Annual
Total other income (expenses)	`NonoperatingIncomeExpense`	$-1.45M	USD	Annual
Total other income (expenses)	`NonoperatingIncomeExpense`	$1.83M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.75M	USD	Annual
Net loss	`NetIncomeLoss`	$-39.75M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-26.32M	USD	1 Quarter
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasic`	$-1.40	USD	Annual
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasic`	$-0.87	USD	1 Quarter
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	30.10M	shares	1 Quarter
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	28.39M	shares	Annual

Cash Flow Statement 51 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-39.75M	USD	Annual
Net loss	`NetIncomeLoss`	$-39.75M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-26.32M	USD	1 Quarter
Depreciation expense	`Depreciation`	-	USD	1 Quarter
Depreciation expense	`Depreciation`	-	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$11.93M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$11.35M	USD	1 Quarter
Realized loss on short-term investments	`IncomeLossFromEquityMethodInvestments`	$-15.02K	USD	1 Quarter
Realized loss on short-term investments	`IncomeLossFromEquityMethodInvestments`	$-666.71K	USD	1 Quarter
Unrealized (gain) loss on short-term investments	`UnrealizedsLossgainOnShorttermInvestments`	$-1.76M	USD	1 Quarter
Unrealized (gain) loss on short-term investments	`UnrealizedsLossgainOnShorttermInvestments`	$1.29M	USD	1 Quarter
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-20.92K	USD	1 Quarter
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	-	USD	1 Quarter
Other receivables	`IncreaseDecreaseInReceivables`	-	USD	1 Quarter
Other receivables	`IncreaseDecreaseInReceivables`	$-512.43K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-945.61K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-6.24M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-839.97K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-522.35K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$870.90K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-1.53M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-16.51M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-19.43M	USD	1 Quarter
Purchase of short-term investments	`PaymentsToAcquireInvestments`	$25.92M	USD	1 Quarter
Purchase of short-term investments	`PaymentsToAcquireInvestments`	$34.77M	USD	1 Quarter
Sale of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$15.89M	USD	1 Quarter
Sale of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$74.77M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-10.03M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$40.00M	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$29.58M	USD	1 Quarter
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from options exercised for common stock	`ProceedsFromStockOptionsExercised`	$64.80K	USD	1 Quarter
Proceeds from options exercised for common stock	`ProceedsFromStockOptionsExercised`	-	USD	1 Quarter
Proceeds from warrants exercised for common stock	`ProceedsFromWarrantExercises`	$300.01K	USD	1 Quarter
Proceeds from warrants exercised for common stock	`ProceedsFromWarrantExercises`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$29.95M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$23.50M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$490.94K	USD	1 Quarter
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$44.93M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$44.44M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$28.89M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.40M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$44.93M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$44.44M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$28.89M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.40M	USD	Point-in-time
Income taxes	`IncomeTaxesPaidNet`	-	USD	1 Quarter
Income taxes	`IncomeTaxesPaidNet`	-	USD	1 Quarter
Interest	`InterestPaid`	-	USD	1 Quarter
Interest	`InterestPaid`	-	USD	1 Quarter

Stockholders Equity 16 line items

Line Item	Tag	Value	Unit	Period
Balance beginning	`StockholdersEquity`	$140.44M	USD	Point-in-time
Balance beginning	`StockholdersEquity`	$210.40M	USD	Point-in-time
Balance beginning	`StockholdersEquity`	$125.47M	USD	Point-in-time
Balance beginning	`StockholdersEquity`	$208.26M	USD	Point-in-time
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$11.93M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$11.35M	USD	1 Quarter
ATM offering, net	`StockIssuedDuringPeriodValueOther`	$29.58M	USD	1 Quarter
Warrant exercised for cash	`StockIssuedDuringPeriodValueNewIssues`	$300.01K	USD	1 Quarter
Options exercised for cash	`StockIssuedDuringPeriodValueStockOptionsExercised`	$64.80K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.75M	USD	Annual
Net loss	`NetIncomeLoss`	$-39.75M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-26.32M	USD	1 Quarter
Balance ending	`StockholdersEquity`	$140.44M	USD	Point-in-time
Balance ending	`StockholdersEquity`	$210.40M	USD	Point-in-time
Balance ending	`StockholdersEquity`	$125.47M	USD	Point-in-time
Balance ending	`StockholdersEquity`	$208.26M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.